Safety and pharmacokinetics of CL-197, a potent compound with low cytotoxicity against HIV-1: a randomized, double-blind, placebo-controlled, first-in-human phase 1 clinical trial. (journals.asm.org)

Authors: Guo Y … Li Y Journal: Antimicrobial Agents and Chemotherapy Published: 2026-09-04 DOI: https://doi.org/10.1128/aac.00984-26